| Homo sapiens |
Acetylcholinesterase |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
6400.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
4700.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
8600.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
25000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Angiotensin-converting enzyme |
Inhibition |
31.0 |
% |
10.1021/jm400813y |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
AC50 |
3200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
88.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cathepsin D |
Ki |
15000.0 |
nM |
10.1021/jm960541s |
| Homo sapiens |
Cathepsin E |
Ki |
9000.0 |
nM |
10.1021/jm960541s |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
3800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 2C9 |
FC |
1.6 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2D6 |
FC |
1.0 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 3A4 |
Activity |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
FC |
1.3 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
14000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Epidermal growth factor receptor erbB1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HEK293 |
Activity |
nan |
None |
10.1073/pnas.0704212104 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-20.52 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-1.6 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
Activity |
-38.0 |
% |
10.1128/aac.00671-07 |
| Homo sapiens |
Homo sapiens |
Activity |
-23.0 |
% |
10.1128/aac.00671-07 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1128/aac.00671-07 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
AUC |
395960.76 |
ng.hr.mL-1 |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
CL |
1.47 |
L/hr |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
Cmax |
99390.0 |
nM |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
Cp |
25.85 |
uM |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
8.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
EC50 |
60000.0 |
nM |
10.1128/aac.01512-09 |
| Homo sapiens |
Homo sapiens |
EC50 |
85000.0 |
nM |
10.1128/aac.01512-09 |
| Homo sapiens |
Homo sapiens |
T1/2 |
4.6 |
hr |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
Tmax |
2.9 |
hr |
10.1128/aac.01115-06 |
| Homo sapiens |
Homo sapiens |
Vd |
9.6 |
l |
10.1128/aac.01115-06 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
26999.8 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
MT2 |
CC50 |
54100.0 |
nM |
10.1128/aac.01766-09 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
6300.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pepsin A |
Ki |
2000.0 |
nM |
10.1021/jm960541s |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
6900.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
29000.1 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
260.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
12999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Receptor protein-tyrosine kinase erbB-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
7500.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Sodium channel protein type V alpha subunit |
AC50 |
50000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
89.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
109.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
99.0 |
% |
10.1021/jm300212s |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
10999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
23715.0 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
33498.3 |
nM |
None |
| Homo sapiens |
Vascular endothelial growth factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
22.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
29.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
37.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
39.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
40.9 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
42.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
66.0 |
nM |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
76.2 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
95.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
120.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
170.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
180.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
184.0 |
nM |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
190.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
204.0 |
nM |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
220.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
230.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
240.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
304.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
310.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
310.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
320.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
350.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
360.0 |
nM |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
380.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
410.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
507.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
580.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
660.0 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
5740.0 |
nM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
6150.0 |
nM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
6300.0 |
nM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
6730.0 |
nM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
7839.0 |
nM |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
nM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
EC50 |
nan |
None |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
0.8 |
None |
10.1128/aac.00906-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
1.2 |
None |
10.1128/aac.00906-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
1.7 |
None |
10.1128/aac.00906-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
3.6 |
None |
10.1128/aac.00906-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
FC |
6.7 |
None |
10.1128/aac.00906-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
1.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
42.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
92.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
100.0 |
nM |
10.1074/jbc.m703938200 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
IC50 |
192.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Inhibition |
nan |
% |
10.1128/aac.01228-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
pCC50 |
4.49 |
uM |
10.1021/jm049454n |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
2.4 |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
3.0 |
None |
10.1128/aac.01228-10 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
6.0 |
None |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
7.7 |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
12.4 |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
14.1 |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
16.0 |
None |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus 1 |
Ratio EC50 |
nan |
None |
10.1128/aac.01132-07 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
ED50 |
300.0 |
uM |
10.1016/j.bmcl.2004.10.018 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
ED90 |
0.1 |
uM |
10.1016/j.bmcl.2004.10.018 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
IC50 |
30.0 |
nM |
10.1021/jm960541s |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
IC50 |
30.0 |
nM |
10.1021/jm9802158 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
IC90 |
100.0 |
nM |
10.1021/jm960541s |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
IC90 |
100.0 |
nM |
10.1021/jm9802158 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
IC90 |
150.0 |
nM |
10.1021/jm960541s |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
Ki |
0.008 |
nM |
10.1016/j.ejmech.2016.07.056 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
Ki |
0.008 |
nM |
10.1021/jm960541s |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
Ki |
0.008 |
nM |
10.1021/jm9802158 |
| Human immunodeficiency virus 1 |
Human immunodeficiency virus type 1 protease |
Ki |
1.0 |
nM |
10.1021/jm960541s |
| Human immunodeficiency virus 1 |
Protease |
Ki |
0.008 |
nM |
10.1128/aac.00401-07 |
| Human immunodeficiency virus 1 |
Protease |
Ki |
nan |
None |
10.1074/jbc.m703938200 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
300.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
EC50 |
330.0 |
nM |
10.1128/aac.01766-09 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
145.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
160.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
300.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
306.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
316.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
400.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
524.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
1106.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
2028.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
2800.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
2908.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
4000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
4100.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
4436.0 |
nM |
10.1128/aac.00870-06 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
4700.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
4800.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
6700.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC50 |
7300.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
700.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
800.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
1700.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
2200.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
2500.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
2600.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
2700.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
3000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
3500.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
4200.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
12000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
14000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
16000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
17000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
23000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
26000.0 |
nM |
10.1128/aac.01284-07 |
| Human immunodeficiency virus 2 |
Human immunodeficiency virus 2 |
IC90 |
29000.0 |
nM |
10.1128/aac.01284-07 |
| Mus musculus |
CAAX prenyl protease 1 homolog |
IC50 |
1200.0 |
nM |
10.1073/pnas.0704212104 |
| Mus musculus |
CAAX prenyl protease 2 |
Activity |
nan |
None |
10.1073/pnas.0704212104 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
12000.0 |
nM |
10.1128/aac.01512-09 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
18000.0 |
nM |
10.1128/aac.01512-09 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
20000.0 |
nM |
10.1128/aac.01512-09 |
| Plasmodium falciparum |
Plasmodium falciparum |
EC50 |
21000.0 |
nM |
10.1128/aac.01512-09 |
| Plasmodium falciparum |
Plasmodium falciparum |
Inhibition |
nan |
% |
10.1128/aac.01512-09 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
5800.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Rattus norvegicus |
CL |
2.833 |
mL.min-1.kg-1 |
10.1021/jm960541s |
| Rattus norvegicus |
Rattus norvegicus |
T1/2 |
5.4 |
hr |
10.1021/jm960541s |
| Rattus norvegicus |
Rattus norvegicus |
Vdss |
0.51 |
L.kg-1 |
10.1021/jm960541s |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
13.32 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.04844 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.18 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
3.26 |
% |
10.21203/rs.3.rs-23951/v1 |
| None |
ADMET |
F |
30.0 |
% |
10.1021/jm960541s |
| None |
ADMET |
Ratio CC50/EC50 |
320.0 |
None |
10.1128/aac.01766-09 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
6.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
1.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
8.0 |
None |
10.1016/j.drudis.2011.05.007 |
| None |
NON-PROTEIN TARGET |
IC50 |
50.0 |
nM |
10.1128/aac.01284-07 |
| None |
NON-PROTEIN TARGET |
IC90 |
400.0 |
nM |
10.1128/aac.01284-07 |
| None |
Unchecked |
Ac50 |
19.95 |
uM |
None |
| None |
Unchecked |
Ac50 |
22.39 |
uM |
None |
| None |
Unchecked |
Ac50 |
25.12 |
uM |
None |
| None |
Unchecked |
AC50 |
19952.6 |
nM |
None |
| None |
Unchecked |
AC50 |
22387.2 |
nM |
None |
| None |
Unchecked |
AC50 |
25120.0 |
nM |
None |
| None |
Unchecked |
Activity |
65.0 |
% |
10.1021/acsmedchemlett.0c00521 |
| None |
Unchecked |
IC50 |
600000.0 |
nM |
10.1021/acsmedchemlett.0c00521 |
| None |
Unchecked |
Ki |
0.008 |
nM |
10.1021/jm0497343 |
| None |
Unchecked |
Potency |
7943.3 |
nM |
None |